Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Nebraska
Pilot study to test the feasibility of adjusting doses based on a prespecified algorithm to reach a 6 month 25(OH)D level of 35-50 ng/ml in end stage renal disease patients.
Age
21–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
likely be able to complete the study, \>3 months on hemodialysis, receiving standard of care through their nephrologist.
You may not be if
on peritoneal dialysis, allergy to vitamin D, liver disease, intestinal disorders that interfere with vitamin D absorption, taking vitamin D \>800 IU per day, 25(OH)D level \>30 ng/ml, glucocorticoids, anticonvulsants or drug therapies for osteoporosis, pregnancy.
